(Q68502006)
Statements
Improved treatment results in the myelocytic subtypes FAB M1-M4 but not in FAB M5 after intensification of induction therapy: results of the German childhood AML studies BFM-78 and BFM-83 (English)
Ritter J
Creutzig U
1 January 1990